Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Combination tirapazamine, cisplatin and radiotherapy highly effective in advanced H&N cancer

Nov. 9, 1999

Banyu presents preclinical pharmacokinetic, metabolic data for J-107088 at recent scientific meeting

Nov. 9, 1999

Novel class of bifunctional anticancer agents discovered at University of Kansas

Nov. 8, 1999

Pharmacia & Upjohn describes anthracycline glycosides and their antitumor activity

Nov. 8, 1999

Interim data fom phase II IntraDose trial in liver cancer indicate positive response

Nov. 8, 1999

Merck dedicates significant resources to development of nonpeptide GnRH antagonists

Nov. 5, 1999

Magainin to begin additional clinical trials of squalamine

Nov. 5, 1999

Lilly discloses methods of inhibiting multidrug resistance

Nov. 4, 1999

Results from lead-in phase of Xcytrin trial support continued patient enrollment

Nov. 4, 1999

NewBiotics enters agreement with Ilex for colon cancer therapy

Nov. 3, 1999

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...